Literature DB >> 23917291

History of kidney stones and the risk of coronary heart disease.

Pietro Manuel Ferraro1, Eric N Taylor, Brian H Eisner, Giovanni Gambaro, Eric B Rimm, Kenneth J Mukamal, Gary C Curhan.   

Abstract

IMPORTANCE: Kidney stone disease is common and may be associated with an increased risk of coronary heart disease (CHD). Previous studies of the association between kidney stones and CHD have often not controlled for important risk factors, and the results have been inconsistent.
OBJECTIVE: To examine the association between a history of kidney stones and the risk of CHD in 3 large prospective cohorts. DESIGN, SETTING, AND PARTICIPANTS: A prospective study of 45,748 men and 196,357 women in the United States without a history of CHD at baseline who were participants in the Health Professionals Follow-up Study (HPFS) (45,748 men aged 40-75 years; follow-up from 1986 to 2010), Nurses' Health Study I (NHS I) (90,235 women aged 30-55 years; follow-up from 1992 to 2010), and Nurses' Health Study II (NHS II) (106,122 women aged 25-42 years; follow-up from 1991 to 2009). The diagnoses of kidney stones and CHD were updated biennially during follow-up. MAIN OUTCOMES AND MEASURES: Coronary heart disease was defined as fatal or nonfatal myocardial infarction (MI) or coronary revascularization. The outcome was identified by biennial questionnaires and confirmed through review of medical records. RESULTS Of a total of 242,105 participants, 19,678 reported a history of kidney stones. After up to 24 years of follow-up in men and 18 years in women, 16,838 incident cases of CHD occurred. After adjusting for potential confounders, among women, those with a reported history of kidney stones had an increased risk of CHD than those without a history of kidney stones in NHS I (incidence rate [IR], 754 vs 514 per 100,000 person-years; multivariable hazard ratio [HR], 1.18 [95% CI, 1.08-1.28]) and NHS II (IR, 144 vs 55 per 100,000 person-years; multivariable HR, 1.48 [95% CI, 1.23-1.78]). There was no significant association in men (IR, 1355 vs 1022 per 100,000 person-years; multivariable HR, 1.06 [95% CI, 0.99-1.13]). Similar results were found when analyzing the individual end points (fatal and nonfatal MI and revascularization). CONCLUSIONS AND RELEVANCE: Among the 2 cohorts of women, a history of kidney stones was associated with a modest but statistically significantly increased risk of CHD; there was no significant association in a separate cohort of men. Further research is needed to determine whether the association is sex-specific.

Entities:  

Mesh:

Year:  2013        PMID: 23917291      PMCID: PMC4019927          DOI: 10.1001/jama.2013.8780

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  41 in total

1.  Increased risk of diabetes in patients with urinary calculi: a 5-year followup study.

Authors:  Shiu-Dong Chung; Yi-Kuang Chen; Herng-Ching Lin
Journal:  J Urol       Date:  2011-09-23       Impact factor: 7.450

2.  Increased 10-year cardiovascular disease and mortality risk scores in asymptomatic patients with calcium oxalate urolithiasis.

Authors:  Hasan Aydin; Faruk Yencilek; Ismet Bilger Erihan; Binnur Okan; Kemal Sarica
Journal:  Urol Res       Date:  2011-05-13

3.  Urolithiasis and coronary heart disease: a note on association.

Authors:  K Westlund
Journal:  Am J Epidemiol       Date:  1973-03       Impact factor: 4.897

4.  Kidney stones and subclinical atherosclerosis in young adults: the CARDIA study.

Authors:  Alexander P Reiner; Arnold Kahn; Brian H Eisner; Mark J Pletcher; Natalia Sadetsky; O Dale Williams; Joseph F Polak; David R Jacobs; Marshall L Stoller
Journal:  J Urol       Date:  2011-01-19       Impact factor: 7.450

5.  Nephrolithiasis is associated with an increased prevalence of cardiovascular disease.

Authors:  Fernando Domingos; Adelaide Serra
Journal:  Nephrol Dial Transplant       Date:  2010-08-13       Impact factor: 5.992

6.  Quantification of osteopontin in the urine of healthy and stone-forming men.

Authors:  T Yasui; K Fujita; Y Hayashi; K Ueda; S Kon; M Maeda; T Uede; K Kohri
Journal:  Urol Res       Date:  1999-08

Review 7.  Osteopontin and calcium stone formation.

Authors:  Jack G Kleinman; Jeffrey A Wesson; Jeremy Hughes
Journal:  Nephron Physiol       Date:  2004

8.  Prevalence of kidney stones in the United States.

Authors:  Charles D Scales; Alexandria C Smith; Janet M Hanley; Christopher S Saigal
Journal:  Eur Urol       Date:  2012-03-31       Impact factor: 20.096

9.  Plasma osteopontin levels are associated with the presence and extent of coronary artery disease.

Authors:  Reiko Ohmori; Yukihiko Momiyama; Hiroaki Taniguchi; Rie Takahashi; Masatoshi Kusuhara; Haruo Nakamura; Fumitaka Ohsuzu
Journal:  Atherosclerosis       Date:  2003-10       Impact factor: 5.162

10.  Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules.

Authors:  Jeffrey A Wesson; Richard J Johnson; Marrilda Mazzali; Anne M Beshensky; Susan Stietz; Ceci Giachelli; Lucy Liaw; Charles E Alpers; William G Couser; Jack G Kleinman; Jeremy Hughes
Journal:  J Am Soc Nephrol       Date:  2003-01       Impact factor: 10.121

View more
  89 in total

Review 1.  Treatment of calcium nephrolithiasis in the patient with hyperuricosuria.

Authors:  Omotayo Arowojolu; David S Goldfarb
Journal:  J Nephrol       Date:  2014-04-01       Impact factor: 3.902

2.  Risk factors: Kidney stones associated with increased CHD risk in women.

Authors:  Alexandra Roberts
Journal:  Nat Rev Cardiol       Date:  2013-08-13       Impact factor: 32.419

3.  The relationship between calcium kidney stones, arterial stiffness and bone density: unraveling the stone-bone-vessel liaison.

Authors:  Antonia Fabris; Pietro Manuel Ferraro; Gabriele Comellato; Chiara Caletti; Francesco Fantin; Gianluigi Zaza; Mauro Zamboni; Antonio Lupo; Giovanni Gambaro
Journal:  J Nephrol       Date:  2014-09-30       Impact factor: 3.902

4.  Baseline chronic kidney disease does not predict long-term renal functional decline after percutaneous nephrolithotomy.

Authors:  Kara L Watts; Abhishek Srivastava; Wilson Lin; Daniel Schoenfeld; Matthew Abramowitz; Joshua M Stern
Journal:  Urolithiasis       Date:  2019-02-12       Impact factor: 3.436

Review 5.  Stones in 2014: Advancing our understanding--aetiology, prevention and treatment.

Authors:  Elias S Hyams; Brian R Matlaga
Journal:  Nat Rev Urol       Date:  2014-12-23       Impact factor: 14.432

6.  Stones, bones, and cardiovascular groans.

Authors:  Eric N Taylor
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-29       Impact factor: 8.237

7.  Educational review: role of the pediatric nephrologists in the work-up and management of kidney stones.

Authors:  Carmen Inés Rodriguez Cuellar; Peter Zhan Tao Wang; Michael Freundlich; Guido Filler
Journal:  Pediatr Nephrol       Date:  2019-01-04       Impact factor: 3.714

8.  Stone formation in patients less than 20 years of age is associated with higher rates of stone recurrence: Results from the Registry for Stones of the Kidney and Ureter (ReSKU).

Authors:  Yi Li; David Bayne; Scott Wiener; Justin Ahn; Marshall Stoller; Thomas Chi
Journal:  J Pediatr Urol       Date:  2020-03-25       Impact factor: 1.830

9.  Independent and interactive effects of kidney stone formation and conventional risk factors for chronic kidney disease: a follow-up study of Japanese men.

Authors:  Ryosuke Ando; Teruo Nagaya; Sadao Suzuki; Hidekatsu Takahashi; Makoto Kawai; Kazumi Taguchi; Shuzo Hamamoto; Atsushi Okada; Takahiro Yasui
Journal:  Int Urol Nephrol       Date:  2021-02-24       Impact factor: 2.370

10.  Kidney Stone Recurrence among Children and Adolescents.

Authors:  Gregory E Tasian; Abdo E Kabarriti; Angela Kalmus; Susan L Furth
Journal:  J Urol       Date:  2016-08-10       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.